Your browser doesn't support javascript.
loading
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.
Wareham, David W; Abdul Momin, M H F; Phee, Lynette M; Hornsey, Michael; Standing, Joseph F.
Afiliação
  • Wareham DW; Antimicrobial Research Group, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.
  • Abdul Momin MHF; Antimicrobial Research Group, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.
  • Phee LM; Antimicrobial Research Group, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.
  • Hornsey M; Antimicrobial Research Group, Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK.
  • Standing JF; Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
J Antimicrob Chemother ; 75(9): 2713, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32653902
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulbactam / Antibacterianos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulbactam / Antibacterianos Idioma: En Ano de publicação: 2020 Tipo de documento: Article